Engerix B 20 µg/1 ml inj. susp. s.c./i.m. pre-filled syr. 1 dose (1 ml)
Active ingredient: Hepatitis B virus surface antigen (recombinant)
View notice details →
News topic
Current shortage notices for the active ingredient Hepatitis B virus surface antigen (recombinant), structured by product, country and reporting period.
4 noticesThe 4 consolidated notices from Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.
Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.
Active ingredient: Hepatitis B virus surface antigen (recombinant)
View notice details →Active ingredient: Hepatitis B virus surface antigen (recombinant)
View notice details →Active ingredient: Hepatitis B virus surface antigen (recombinant)
View notice details →Active ingredient: Hepatitis A Virus Antigene (Hav Antigen) Vaccin; Hepatitis B virus surface antigen (recombinant)
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →